M. Mar

Serum Levels of Brain-Derived Neurotrophic Factor and Cortisol to Sulfate of Dehydroepiandrosterone Molar Ratio Associated With Clinical Response to l-Theanine as Augmentation of Antipsychotic Therapy in Schizophrenia and Schizoaffective Disorder Patients

Abraham Weizman, M. Ritsner, Y. Ratner, 2011, Clinical neuropharmacology.

Zuclopenthixol, D1/D2 antagonist, for treatment of chronic aggressive schizophrenia and psychotic oligophrenic patients

A. Weizman, A. Valevski, A. Grinshpoon, 1998, European Psychiatry.

L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.

M. Ritsner, Y. Ratner, V. Lerner, 2011, The Journal of clinical psychiatry.

Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility

M. Ritsner, A. Grinshpoon, M. Arbitman, 2013, Psychiatry Research.